Model
Edge
Revance Therapeutics Inc.
0001704317
Filing Type
4
Filing Date
5/2/2024
Updated
5/3/24, 6:43 AM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership